Type 2 diabetes mellitus increases liver transplant-free mortality in patients with cirrhosis: A systematic review and meta-analysis.

Background: The impact of type 2 diabetes mellitus (T2DM) on the prognosis and complications of liver cirrhosis is not fully clarified.

Aim: To clarify the mortality and related risk factors as well as complications in cirrhotic patients with T2DM.

Methods: We searched PubMed, EMBASE, and the Cochrane Library from their inception to December 1, 2020 for cohort studies comparing liver transplant-free mortality, hepatocellular carcinoma (HCC), ascites, spontaneous bacterial peritonitis (SBP), variceal bleeding, and hepatic encephalopathy (HE) in cirrhotic patients with without T2DM. Odds ratios (ORs) were combined by using fixed-effects or random-effects models with RevMan software.

Results: The database search generated a total of 17 cohort studies that met the inclusion criteria. Among these studies, eight reported the risk of mortality, and eight reported the risk of HCC. Three studies provided SBP rates, and two documented ascites rates. Four articles focused on HE rates, and three focused on variceal bleeding rates. Meta-analysis indicated that T2DM was significantly associated with an increased risk of liver transplant-free mortality [OR: 1.28, 95% confidence intervals (CI): 1.16-1.41, < 0.0001] and HCC incidence (OR: 1.82, 95%CI: 1.32-2.51, = 0.003). The risk of SBP was not significantly increased (OR: 1.16 95%CI: 0.86-1.57, = 0.34). Additionally, T2DM did not significantly increase HE (OR: 1.31 95%CI: 0.97-1.77, = 0.08), ascites (OR: 1.11 95%CI: 0.84-1.46, = 0.46), and variceal bleeding (OR: 1.34, 95%CI: 0.99-1.82, = 0.06).

Conclusion: The findings suggest that cirrhotic patients with T2DM have a poor prognosis and high risk of HCC. T2DM may not be associated with an increased risk of SBP, variceal bleeding, ascites, or HE in cirrhotic patients with T2DM.